Sutter Health, UPMC, and DNAnexus Initiate Collaboration to Improve Personalized Treatments for People with Multiple Sclerosis
DNAnexus, and the not-for-profit Sutter Health network announced the first large-scale clinico-genomic multiple sclerosis (MS) research study conducted by a leading healthcare system . . .
To continue reading this article…
Start your monthly or annual subscription to HIT Leaders & News today!
A monthly Standard subscription to all our regular news articles costs only $12.00 per month, or $144.00 for an annual Standard subscription.
Already a subscriber? Log in
DNAnexus, DNAnexus Apollo Platform, Precision Medicine, Sutter Health, UPMC, UPMC Genome Center